REQUEST A DEMO
Total
USD $0.00
Search more companies

Biotecnologia y Bioingenieria Core S.A. (Colombia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Biotecnologia y Bioingenieria Core S.A. Profile Updated: July 13, 2022
Buy our report for this company USD 19.99 Most recent financial data: 2021 Available in: English & Spanish Download a sample report

Biotecnologia y Bioingenieria Core S.A. is a company in Colombia, with a head office in Barranquilla. It operates in the Pharmaceutical Preparation Manufacturing sector. It was established on January 14, 2009. 5 (2022) employees currently work for Biotecnologia y Bioingenieria Core S.A..

Headquarters
Cl 52 Cr 92 102
Barranquilla; Atlantico;

Contact Details: Purchase the Biotecnologia y Bioingenieria Core S.A. report to view the information.

Basic Information
Total Employees:
Purchase the Biotecnologia y Bioingenieria Core S.A. report to view the information.
Outstanding Shares:
Purchase the Biotecnologia y Bioingenieria Core S.A. report to view the information.
Incorporation Date:
January 14, 2009
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Deputy Member of the Board of Directors
Purchase this report to view the information.
Deputy Member of the Board of Directors
Company Performance
Financial values in the chart are available after Biotecnologia y Bioingenieria Core S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Total assets
0%
Total equity
277.52%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?